These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 10380889)
1. Early cellular abnormalities induced by RET/PTC1 oncogene in thyroid-targeted transgenic mice. Cho JY; Sagartz JE; Capen CC; Mazzaferri EL; Jhiang SM Oncogene; 1999 Jun; 18(24):3659-65. PubMed ID: 10380889 [TBL] [Abstract][Full Text] [Related]
2. The roles of phosphotyrosines-294, -404, and -451 in RET/PTC1-induced thyroid tumor formation. Buckwalter TL; Venkateswaran A; Lavender M; La Perle KM; Cho JY; Robinson ML; Jhiang SM Oncogene; 2002 Nov; 21(53):8166-72. PubMed ID: 12444552 [TBL] [Abstract][Full Text] [Related]
3. Thyroid carcinomas in RET/PTC transgenic mice. Jhiang SM; Cho JY; Furminger TL; Sagartz JE; Tong Q; Capen CC; Mazzaferri EL Recent Results Cancer Res; 1998; 154():265-70. PubMed ID: 10027006 [TBL] [Abstract][Full Text] [Related]
4. Role of H2O2 in RET/PTC1 chromosomal rearrangement produced by ionizing radiation in human thyroid cells. Ameziane-El-Hassani R; Boufraqech M; Lagente-Chevallier O; Weyemi U; Talbot M; Métivier D; Courtin F; Bidart JM; El Mzibri M; Schlumberger M; Dupuy C Cancer Res; 2010 May; 70(10):4123-32. PubMed ID: 20424115 [TBL] [Abstract][Full Text] [Related]
5. Creation and characterization of a doxycycline-inducible mouse model of thyroid-targeted RET/PTC1 oncogene and luciferase reporter gene coexpression. Knostman KA; Venkateswaran A; Zimmerman B; Capen CC; Jhiang SM Thyroid; 2007 Dec; 17(12):1181-8. PubMed ID: 18004977 [TBL] [Abstract][Full Text] [Related]
6. Concurrent overexpression of RET/PTC1 and TTF1 confers tumorigenicity to thyrocytes. Endo T; Kobayashi T Endocr Relat Cancer; 2013 Dec; 20(6):767-76. PubMed ID: 24014739 [TBL] [Abstract][Full Text] [Related]
7. RET gene rearrangements (RET/PTC1 and RET/PTC3) in papillary thyroid carcinomas from an iodine-rich country (Japan). Nakazawa T; Kondo T; Kobayashi Y; Takamura N; Murata S; Kameyama K; Muramatsu A; Ito K; Kobayashi M; Katoh R Cancer; 2005 Sep; 104(5):943-51. PubMed ID: 16015630 [TBL] [Abstract][Full Text] [Related]
8. Targeted expression of the ret/PTC1 oncogene induces papillary thyroid carcinomas. Jhiang SM; Sagartz JE; Tong Q; Parker-Thornburg J; Capen CC; Cho JY; Xing S; Ledent C Endocrinology; 1996 Jan; 137(1):375-8. PubMed ID: 8536638 [TBL] [Abstract][Full Text] [Related]
9. Loss of p53 promotes anaplasia and local invasion in ret/PTC1-induced thyroid carcinomas. La Perle KM; Jhiang SM; Capen CC Am J Pathol; 2000 Aug; 157(2):671-7. PubMed ID: 10934169 [TBL] [Abstract][Full Text] [Related]
10. RET/PTC1 oncogene signaling in PC Cl 3 thyroid cells requires the small GTP-binding protein Rho. Barone MV; Sepe L; Melillo RM; Mineo A; Santelli G; Monaco C; Castellone MD; Tramontano D; Fusco A; Santoro M Oncogene; 2001 Oct; 20(48):6973-82. PubMed ID: 11704822 [TBL] [Abstract][Full Text] [Related]
11. Thyroid-stimulating hormone promotes growth of thyroid carcinomas in transgenic mice with targeted expression of the ret/PTC1 oncogene. Sagartz JE; Jhiang SM; Tong Q; Capen CC Lab Invest; 1997 Mar; 76(3):307-18. PubMed ID: 9121114 [TBL] [Abstract][Full Text] [Related]
12. The RET/PTC3 oncogene: metastatic solid-type papillary carcinomas in murine thyroids. Powell DJ; Russell J; Nibu K; Li G; Rhee E; Liao M; Goldstein M; Keane WM; Santoro M; Fusco A; Rothstein JL Cancer Res; 1998 Dec; 58(23):5523-8. PubMed ID: 9850089 [TBL] [Abstract][Full Text] [Related]
13. Retinoic acid increases sodium/iodide symporter mRNA levels in human thyroid cancer cell lines and suppresses expression of functional symporter in nontransformed FRTL-5 rat thyroid cells. Schmutzler C; Winzer R; Meissner-Weigl J; Köhrle J Biochem Biophys Res Commun; 1997 Nov; 240(3):832-8. PubMed ID: 9398654 [TBL] [Abstract][Full Text] [Related]
14. The TRK-T1 fusion protein induces neoplastic transformation of thyroid epithelium. Russell JP; Powell DJ; Cunnane M; Greco A; Portella G; Santoro M; Fusco A; Rothstein JL Oncogene; 2000 Nov; 19(50):5729-35. PubMed ID: 11126359 [TBL] [Abstract][Full Text] [Related]
15. Development of mammary and cutaneous gland tumors in transgenic mice carrying the RET/PTC1 oncogene. Portella G; Salvatore D; Botti G; Cerrato A; Zhang L; Mineo A; Chiappetta G; Santelli G; Pozzi L; Vecchio G; Fusco A; Santoro M Oncogene; 1996 Nov; 13(9):2021-6. PubMed ID: 8934550 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of heat shock protein 90, a novel RET/PTC1-associated protein, increases radioiodide accumulation in thyroid cells. Marsee DK; Venkateswaran A; Tao H; Vadysirisack D; Zhang Z; Vandre DD; Jhiang SM J Biol Chem; 2004 Oct; 279(42):43990-7. PubMed ID: 15302866 [TBL] [Abstract][Full Text] [Related]
17. Induction of a proinflammatory program in normal human thyrocytes by the RET/PTC1 oncogene. Borrello MG; Alberti L; Fischer A; Degl'innocenti D; Ferrario C; Gariboldi M; Marchesi F; Allavena P; Greco A; Collini P; Pilotti S; Cassinelli G; Bressan P; Fugazzola L; Mantovani A; Pierotti MA Proc Natl Acad Sci U S A; 2005 Oct; 102(41):14825-30. PubMed ID: 16203990 [TBL] [Abstract][Full Text] [Related]
18. [Oncogenes RET/PTC and mechanisms of their involvement in thyroid cancerogenesis]. Voskoboĭnyk LH Ukr Biokhim Zh (1999); 2009; 81(6):17-25. PubMed ID: 20387655 [TBL] [Abstract][Full Text] [Related]
19. Conditional expression of RET/PTC induces a weak oncogenic drive in thyroid PCCL3 cells and inhibits thyrotropin action at multiple levels. Wang J; Knauf JA; Basu S; Puxeddu E; Kuroda H; Santoro M; Fusco A; Fagin JA Mol Endocrinol; 2003 Jul; 17(7):1425-36. PubMed ID: 12690093 [TBL] [Abstract][Full Text] [Related]
20. XB130, a tissue-specific adaptor protein that couples the RET/PTC oncogenic kinase to PI 3-kinase pathway. Lodyga M; De Falco V; Bai XH; Kapus A; Melillo RM; Santoro M; Liu M Oncogene; 2009 Feb; 28(7):937-49. PubMed ID: 19060924 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]